Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 5, 2013, Pages 979-986

  Li, Xu Hui ^a   Chen, Xiang Jun ^a   Ou, Wen Bin ^a   Zhang, Qian ^b   Lv, Zhi Rong ^a   Zhan, Yi ^a   Ma, Long ^b   Huang, Tao ^c   Yan, Yong Bin ^a   Zhou, Hai Meng ^a  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Creatine kinase B; Glycolysis; Metabolism; Ovarian cancer

Indexed keywords

CREATINE KINASE; CREATINE KINASE B; DOXORUBICIN; LACTIC ACID; P21 ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ENERGY METABOLISM; FEEDBACK SYSTEM; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; HYPOXIA; METABOLISM; MITOCHONDRIAL RESPIRATION; OVARY CANCER; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CREATINE KINASE; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; GLYCOLYSIS; HUMANS; ISOENZYMES; OVARIAN NEOPLASMS; TRANSFECTION; UP-REGULATION;

VERTEBRATA;

EID: 84874940202     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.02.003     Document Type: Article

References (66)

1. T. Atsumi, J. Chesney, C. Metz, L. Leng, S. Donnelly, and Z. Makita High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers Cancer Research 62 2002 5881 5887
2. M. Balasubramani, B.W. Day, R.E. Schoen, and R.H. Getzenberg Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer Cancer Research 66 2006 763 769
3. M.F. Beal Energetics in the pathogenesis of neurodegenerative diseases Trends in Neurosciences 23 2000 298 304
4. S. Becker, and F. Schneider Investigations on the function of creatine kinase in Ehrlich ascites tumor cells Biological Chemistry Hoppe-Seyler 370 1989 357 364
5. A. Bellacosa, D. de Feo, A.K. Godwin, D.W. Bell, J.Q. Cheng, and D.A. Altomare Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas International Journal of Cancer 64 1995 280 285
6. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, and J.P. Brown Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497 1501
7. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nature Reviews Cancer 11 2011 85 95
8. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, and J.C. Milne AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
9. O. Cazzalini, A.I. Scovassi, M. Savio, L.A. Stivala, and E. Prosperi Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response Mutation Research 704 2010 12 20
10. Z. Chen, J. Li, T.J. Zhao, X.H. Li, F.G. Meng, and H. Mu Metallothioneins protect cytosolic creatine kinases against stress induced by nitrogen-based oxidants Biochemical Journal 441 2012 623 632
11. Z. Chen, T.J. Zhao, J. Li, Y.S. Gao, F.G. Meng, and Y.B. Yan Slow skeletal muscle myosin-binding protein-C (MyBPC1) mediates recruitment of muscle-type creatine kinase (CK) to myosin Biochemical Journal 436 2011 437 445
12. V. Chopin, R.A. Toillon, N. Jouy, and X. Le Bourhis P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells Oncogene 23 2004 21 29
13. O. Coqueret New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment Trends in Cell Biology 13 2003 65 70
14. G.P. Dotto p21(WAF1/Cip1): more than a break to the cell cycle? Biochimica et Biophysica Acta 1471 2000 M43 M56
15. K. Duvel, J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, and A.L. Souza Activation of a metabolic gene regulatory network downstream of mTOR complex 1 Molecular Cell 39 2010 171 183
16. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, and J.M. Trent WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
17. R.L. Elstrom, D.E. Bauer, M. Buzzai, R. Karnauskas, M.H. Harris, and D.R. Plas Akt stimulates aerobic glycolysis in cancer cells Cancer Research 64 2004 3892 3899
18. S. Feng, T.J. Zhao, H.M. Zhou, and Y.B. Yan Effects of the single point genetic mutation D54G on muscle creatine kinase activity, structure and stability International Journal of Biochemistry & Cell Biology 39 2007 392 401
19. I. Garcia-Cao, M.S. Song, R.M. Hobbs, G. Laurent, C. Giorgi, and V.C. de Boer Systemic elevation of PTEN induces a tumor-suppressive metabolic state Cell 149 2012 49 62
20. H. Hara, H. Aizaki, M. Matsuda, F. Shinkai-Ouchi, Y. Inoue, and K. Murakami Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein Journal of Virology 83 2009 5137 5147
21. T. Hornemann, M. Stolz, and T. Wallimann Isoenzyme-specific interaction of muscle-type creatine kinase with the sarcomeric M-line is mediated by NH(2)-terminal lysine charge-clamps The Journal of Cell Biology 149 2000 1225 1234
22. R.F. Huang, Y.H. Ho, H.L. Lin, J.S. Wei, and T.Z. Liu Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells The Journal of Nutrition 129 1999 25 31
23. H.G. Huddleston, K.K. Wong, W.R. Welch, R.S. Berkowitz, and S.C. Mok Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker Gynecologic Oncology 96 2005 77 83
24. R. Kaddurah-Daouk, J.W. Lillie, G.H. Daouk, M.R. Green, R. Kingston, and P. Schimmel Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a Molecular and Cellular Biology 10 1990 1476 1483
25. J.W. Kim, and C.V. Dang Cancer's molecular sweet tooth and the Warburg effect Cancer Research 66 2006 8927 8930
26. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metabolism 3 2006 177 185
27. T. Kraft, V. Nier, B. Brenner, and T. Wallimann Binding of creatine kinase to the I-band of skinned skeletal muscle fibers is mediated by glycolytic enzymes: an in situ biochemical approach Biophysical Journal 70 1996
28. J.W. Kuiper, R. van Horssen, F. Oerlemans, W. Peters, M.M. van Dommelen, and M.M. te Lindert Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility PLoS ONE 4 2009 e5030
29. X.H. Li, Z. Chen, Y.S. Gao, Y.B. Yan, F. Zhang, and F.G. Meng Generation of the oxidized form protects human brain type creatine kinase against cystine-induced inactivation International Journal of Biological Macromolecules 48 2011 239 242
30. H. Lincet, L. Poulain, J.S. Remy, E. Deslandes, F. Duigou, and P. Gauduchon The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells Cancer Letters 161 2000 17 26
31. V.B. Mahajan, K.S. Pai, A. Lau, and D.D. Cunningham Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton Proceedings of the National Academy of Sciences of the United States of America 97 2000 12062 12067
32. K. Martin, E. Winslow, M. Okeefe, V. Khandekar, A. Hamlin, and J. Lillie Specific targeting of tumor cells by the creatine analog cyclocreatine International Journal of Oncology 9 1996 993 999
33. K.J. Martin, S.F. Chen, G.M. Clark, D. Degen, M. Wajima, and D.D. Von Hoff Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells Journal of the National Cancer Institute 86 1994 608 613
34. S.M. Mooney, K. Rajagopalan, B.H. Williams, Y. Zeng, C.S. Christudass, and Y. Li Creatine kinase brain overexpression protects colorectal cells from various metabolic and non-metabolic stresses Journal of Cellular Biochemistry 112 2011 1066 1075
35. V. Nogueira, Y. Park, C.C. Chen, P.Z. Xu, M.L. Chen, and I. Tonic Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis Cancer Cell 14 2008 458 470
36. E. O'Gorman, G. Beutner, T. Wallimann, and D. Brdiczka Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain Biochimica et Biophysica Acta 1276 1996 161 170
37. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and N.C. Denko HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metabolism 3 2006 187 197
38. L. Pellerin Lactate as a pivotal element in neuron-glia metabolic cooperation Neurochemistry International 43 2003 331 338
39. R.B. Robey, and N. Hay Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt Oncogene 25 2006 4683 4696
40. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis Seminars in Cancer Biology 19 2009 25 31
41. B.P. Rubin, S. Singer, C. Tsao, A. Duensing, M.L. Lux, and R. Ruiz KIT activation is a ubiquitous feature of gastrointestinal stromal tumors Cancer Research 61 2001 8118 8121
42. A. Salin-Cantegrel, M. Shekarabi, S. Holbert, P. Dion, D. Rochefort, and J. Laganiere HMSN/ACC truncation mutations disrupt brain-type creatine kinase-dependent activation of K+/Cl- co-transporter 3 Human Molecular Genetics 17 2008 2703 2711
43. U. Schlattner, M. Tokarska-Schlattner, and T. Wallimann Mitochondrial creatine kinase in human health and disease Biochimica et Biophysica Acta 1762 2006 164 180
44. P. Scholnick, D. Lang, and E. Racker Regulatory mechanisms in carbohydrate metabolism IX. Stimulation of aerobic glycolysis by energy-linked ion transport and inhibition by dextran sulfate Journal of Biological Chemistry 248 1973 5175
45. J.B. Shatton, H.P. Morris, and S. Weinhouse Creatine kinase activity and isozyme composition in normal tissues and neoplasms of rats and mice Cancer Research 39 1979 492 501
46. J.B. Shin, F. Streijger, A. Beynon, T. Peters, L. Gadzala, and D. McMillen Hair bundles are specialized for ATP delivery via creatine kinase Neuron 53 2007 371 386
47. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer Journal for Clinicians 61 2011 212 236
48. P. Singh, M. Salih, J.J. Leddy, and B.S. Tuana The muscle-specific calmodulin-dependent protein kinase assembles with the glycolytic enzyme complex at the sarcoplasmic reticulum and modulates the activity of glyceraldehyde-3-phosphate dehydrogenase in a Ca2+/calmodulin-dependent manner Journal of Biological Chemistry 279 2004 35176 35182
49. S.X. Skapek, J. Rhee, D.B. Spicer, and A.B. Lassar Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase Science 267 1995 1022 1024
50. J.E. Skeen, P.T. Bhaskar, C.C. Chen, W.S. Chen, X.D. Peng, and V. Nogueira Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner Cancer Cell 10 2006 269 280
51. S.P. Staal Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma Proceedings of the National Academy of Sciences of the United States of America 84 1987 5034 5037
52. S. Sumitani, K. Goya, J.R. Testa, H. Kouhara, and S. Kasayama Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts Endocrinology 143 2002 820 828
53. D.A. Tennant, R.V. Duran, and E. Gottlieb Targeting metabolic transformation for cancer therapy Nature Reviews Cancer 10 2010 267 277
54. M. Tokarska-Schlattner, M. Zaugg, C. Zuppinger, T. Wallimann, and U. Schlattner New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics Journal of Molecular and Cellular Cardiology 41 2006 389 405
55. S.H. Tsung Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms Clinical Chemistry 29 1983 2040 2043
56. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nature Reviews Cancer 2 2002 489 501
57. T. Waldman, K.W. Kinzler, and B. Vogelstein p21 is necessary for the p53-mediated G1 arrest in human cancer cells Cancer Research 55 1995 5187 5190
58. T. Wallimann, and W. Hemmer Creatine kinase in non-muscle tissues and cells Molecular and Cellular Biochemistry 133-134 1994 193 220
59. T. Wallimann, H. Moser, and H.M. Eppenberger Isoenzyme-specific localization of M-line bound creatine kinase in myogenic cells Journal of Muscle Research and Cell Motility 4 1983 429 441
60. T. Wallimann, T. Schnyder, J. Schlegel, M. Wyss, G. Wegmann, and A.M. Rossi Subcellular compartmentation of creatine kinase isoenzymes, regulation of CK and octameric structure of mitochondrial CK: important aspects of the phosphoryl-creatine circuit Progress in Clinical & Biological Research 315 1989 159 176
61. T. Wallimann, M. Wyss, D. Brdiczka, K. Nicolay, and Eppenberger HM Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis Biochemical Journal 281 (Pt1) 1992 21 40
62. O. Warburg On the origin of cancer cells Science 123 1956 309 314
63. J. Wendt, S. Radetzki, C. von Haefen, P.G. Hemmati, D. Guner, and K. Schulze-Osthoff Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells Oncogene 25 2006 972 980
64. M. Wyss, J. Smeitink, R.A. Wevers, and T. Wallimann Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism Biochimica et Biophysica Acta 1102 1992 119 166
65. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, and R. Kobayashi Beach D. p21 is a universal inhibitor of cyclin kinases Nature 366 1993 701 704
66. N. Zarghami, M. Giai, H. Yu, R. Roagna, R. Ponzone, and D. Katsaros Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients British Journal of Cancer 73 1996 386 390